1. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
    Louise Marchandet et al, 2021, Cancers CrossRef
  2. Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells
    Tomohiro Fujiwara et al, 2016, Stem Cells International CrossRef
  3. Discovery of N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity
    Jinxin Che et al, 2021, Journal of Medicinal Chemistry CrossRef
  4. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
    Martina Godel et al, 2020, International Journal of Molecular Sciences CrossRef
  5. Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction
    Nutnicha Sirikaew et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Evolutionary and cellular analysis of the ‘dark’ pseudokinase PSKH2
    Dominic P. Byrne et al, 2023, Biochemical Journal CrossRef
  7. Bone Sarcomas: From Biology to Targeted Therapies
    Nathalie Gaspar et al, 2012, Sarcoma CrossRef
  8. Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
    Morgane Lallier et al, 2021, Cells CrossRef
  9. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
    Claudia Maria Hattinger et al, 2021, Cancers CrossRef
  10. Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
    AeRang Kim et al, 2020, Sarcoma CrossRef
  11. Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells
    Xiaodong Mu et al, 2013, Sarcoma CrossRef
  12. Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines
    Cecilia Garofalo et al, 2015, Frontiers in Endocrinology CrossRef
  13. CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells
    Jia-Sin Yang et al, 2019, Molecules CrossRef